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Abstract
Background: The incidence of pediatric infections due to community-associated methicillin-resistant Staphylococcus 
aureus (CA-MRSA), including children with no identifiable risk factors, has increased worldwide in the last decade. This 
suggests that healthy children may constitute a reservoir of MRSA in the community. In this study, nested within a 
larger one on nasopharyngeal ecology, we aimed to: (i) evaluate the prevalence of MRSA colonizing young children in 
Portugal; and (ii) compare results with those obtained in a study conducted a decade ago, when this prevalence was 
<0.5%.
Methods: In the years 2006, 2007, and 2009, nasopharyngeal samples were obtained from 2,100 children aged up to 6 
years attending day-care centers. S. aureus were isolated by routine procedures and strains were tested for 
susceptibility against a panel of 12 antimicrobial agents. MRSA isolates were further characterized by SmaI-PFGE 
profiling, MLST, spa typing, SCCmec typing, and presence of virulence factors.
Results: Seventeen percent of the children carried S. aureus. Among the 365 isolates, non-susceptibility rates were 88% 
to penicillin, 14% to erythromycin, 6% to clindamycin, 2% to tetracycline, and <1% to oxacillin, rifampicin, ciprofloxacin, 
and SXT. Three MRSA strains were isolated. These had properties of CA-MRSA, such as low-level resistance to oxacillin 
and limited resistance to non-beta-lactams. Two CA-MRSA were related to USA700 (ST72-IV): one was ST72-IVc, spa 
type t148; the other was ST939-IVa (ST939 is a single locus variant (SLV) of ST72), spa type t324. The third strain was 
related to USA300 (ST8-IV) being characterized by ST931 (SLV of ST8)-VI, spa type t008. The three MRSA strains were 
PVL-negative, but all carried LukE-LukD leukocidin, hemolysins gamma, gamma variant and beta, and staphylococcal 
enterotoxin sel.
Conclusions: Our results, based on analysis of S. aureus isolated from nasopharyngeal samples, suggest that in Portugal 
the prevalence of CA-MRSA carriage in healthy young children remains extremely low favoring the exclusion of this 
group as a reservoir of such isolates.
Background
Staphylococcus aureus colonizes asymptomatically
mainly the anterior nares of humans. It is also a frequent
cause of clinically important infections [1]. Methicillin-
resistant S. aureus (MRSA) emerged in the 1960s, shortly
after the introduction of methicillin in clinical practice,
through the acquisition of the mecA gene. The gene mecA
encodes for a low affinity penicillin binding protein,
PBP2A, and is carried by the staphylococcal chromo-
somal cassette mec (SCCmec) [2,3]. Molecular character-
ization of a large collection of isolates from different
geographic regions showed that SCCmec  has been
acquired in more than one event by already epidemic
genetic backgrounds, giving rise to five main pandemic
clones that have spread worldwide [4,5]. Nowadays,
MRSA prevalence in hospitals can range from less than
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5% in countries from Northern Europe and The Nether-
lands, to more than 70% in Japan and Hong Kong [6,7].
Three decades after the emergence of MRSA, when
infection control policies aimed to decrease the preva-
lence of MRSA in hospitals of several countries were
being implemented MRSA changed its epidemiology.
From a restricted hospital-associated pathogen, MRSA
made its way into the community [8]. During the last
decade, an increasing incidence of infections in the com-
munity due to MRSA has been reported [9]. In particular,
pediatric infections due to community-associated MRSA
(CA-MRSA) among children with no identifiable predis-
posing risks for health-care associated infection have
been documented worldwide [10-12]. A major and unset-
tled issue in the worldwide emergence of CA-MRSA is
the source of such isolates in the community. The above-
mentioned observations led some authors to propose that
healthy children might constitute an asymptomatic reser-
voir of CA-MRSA [13].
While numerous surveillance programs have been pro-
ducing information on resistance patterns and molecular
types of S. aureus in hospitals, relatively little information
is available on strains of this species that colonize healthy
human populations. Information on this issue has
become particularly important with the worldwide emer-
gence of drug resistant strains - particularly epidemic
MRSA lineages - outside hospitals, in the "healthy"
human community.
In Portugal, the prevalence of nosocomial MRSA varies
widely between hospitals but, overall, remains among the
highest (53%) in Europe [6,14]. Moreover, the prevalence
of MRSA causing skin and soft tissue infections (SSTIs)
in Portugal was the highest in Europe between 1998 and
2004 [15]. However, the carriage and infection rates of
MRSA in the community remain mostly unknown.
An earlier study performed in Portugal on the composi-
tion of S. aureus flora colonizing healthy human popula-
tions provided a striking demonstration on the virtual
absence of MRSA in healthy humans in the late 1990-s
[16], i.e., at a time when MRSA strains were already con-
tributing to over 50% of S. aureus infections in Portu-
guese hospitals. Indeed, of five MRSA out of 285 S.
aureus  isolates recovered from 2,111 children in that
study, three were related to nosocomial clones. The other
two were of ST82 and had low-level resistance to oxacillin
[16].
In this report we examined a large collection of
nasopharyngeal samples from healthy children taken
between 2006 and 2009 for S. aureus and for the presence
and/or frequency of MRSA strains. The comparison of
this time period with the previous study encompasses the
worldwide emergence of CA-MRSA and thus should pro-
vide an unbiased sample to monitor whether significant
changes in the representation of MRSA in this population
have occurred. To achieve such goal, we enrolled over
2,000 children between 2006 and 2009. Participants were
enrolled in two areas: Oeiras (urban municipality) and
Montemor-o-Novo (rural municipality). To our best
knowledge, this is one of the largest studies conducted so
far worldwide aiming to identify CA-MRSA in this risk
group.
Methods
In the winter months of January-March of 2006, 2007,
and 2009, as part of an ongoing study on colonization
patterns by Streptococcus pneumoniae (R. Sá-Leão,
unpublished data, [17] nasopharyngeal swabs were col-
lected from children aged 4 months to 6 years attending
DCCs in the urban area of Oeiras. In 2009, the study was
extended to the rural area of Montemor-o-Novo. The
DCCs were selected to cover the spectrum of social back-
grounds found in both areas. Approval for the study was
obtained from the Ministry of Education and Directors of
DCCs. Parents or guardians gave written informed con-
sent, and a questionnaire was filled in with information
on illnesses, antibiotic consumption, and attendance to
hospitals within the six months preceding sampling.
In each year, a single sample was collected from each
child. Overall, 2,100 samples were obtained: 571 in 2006,
538 in 2007, and 991 in 2009 (611 from Oeiras and 380
from Montemor-o-Novo).
Nasopharyngeal swabs were taken as described [17],
and inoculated within four hours onto mannitol salt agar
(Difco, Detroit, MI). Plates were incubated in aerobic
conditions for 18 h-48 h at 37°C. Single morphologically
distinct mannitol-positive colonies were isolated and
pure cultures were tested for coagulase production by
using Staphytect Plus (Oxoid, Hampshire, England),
according to the manufacturers' instructions. Cultures
that were mannitol-positive and coagulase-negative were
also tested with Coagulase Plasma Rabbit (Becton, Dick-
inson and Company, Sparks, MD), according to the man-
ufacturers' instructions. Cultures that were mannitol-
positive and coagulase-positive were considered to be S.
aureus.
Antimicrobial susceptibility to penicillin, oxacillin,
erythromycin, clindamycin, tetracycline, vancomycin,
ciprofloxacin, rifampicin, linezolid, quinupristin/dalfo-
pristin, gentamicin, and trimethropim/sulphamethox-
azole (SXT) was tested by disk diffusion, according to the
Clinical Laboratory Standards Institute recommenda-
tions and definitions for all S. aureus isolates[18]. Disks
were purchased from Oxoid, Hampshire, England. Iso-
lates were classified as either susceptible or non-suscepti-
ble, the latter classification including isolates with both
intermediate and resistant phenotypes.
All isolates showing an inhibition zone smaller than 20
mm surrounding the oxacillin disk were screened by PCRTavares et al. BMC Infectious Diseases 2010, 10:110
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for the presence of the mecA gene using primers mecAP4
and mecAP7 [19]. MICs to oxacillin were determined for
all isolates and to vancomycin for MRSA isolates only;
MICs were determined by Etest (AB Biodisk, Slona, Swe-
den).
MRSA isolates were further characterized by pulsed-
field gel electrophoresis (PFGE) [20], spa  typing [21],
multilocus sequence typing (MLST) [22], and SCCmec
typing [4,23-25]. The presence of genes coding for viru-
lence factors Panton-Valentine leukocidin (pvl), LukE-
LukD leukocidin (lukED), class F leukocidin (lukM),
staphylococcal enterotoxins (sea-e,  seg-j,  sep,  sel), toxic
shock syndrome toxin (tsst), exfoliative toxins (eta, etb,
etd), and hemolysins (gamma [hlg], gamma variant [hlgv],
and beta [hlb]) was screened by multiplex PCR reactions
as previously described [26-28].
The two MRSA isolates recovered from children in
1997 (during the previous study) that were not associated
with nosocomial clones were also characterized by spa
typing and SCCmec typing, and the presence for viru-
lence genes was screened, as above [16].
Results
S. aureus carriage
A total of 2,100 samples were obtained. The mean age of
the participants was 3.5 years and 52.4% were male. S.
aureus  were isolated from 17.4% of the 2,100 samples,
ranging from 13.2% to 21.6% depending on the sampling
year and origin of isolates (Table 1). In line with previous
observations, [29-31] carriage of S. aureus was signifi-
cantly associated with age ranging from 6.3% among chil-
dren aged less than two years and steadily increasing up
to 27.5% among those aged six years (data not shown).
Antimicrobial susceptibility
Among the 365 S. aureus, 11.5% were susceptible to all
antibiotics tested and the frequency did not vary signifi-
cantly within the four collections.
Non-susceptibility rates were 88.5% to penicillin, 14.0%
to erythromycin, 5.5% to clindamycin, 2.2% to tetracy-
cline, and <1% to oxacillin (three isolates), rifampicin
(three isolates), ciprofloxacin (two isolates), and SXT
(single isolate). All isolates were susceptible to vancomy-
cin, linezolid, quinupristin/dalfopristin, and gentamicin.
Antibiotic resistant rates to individual antibiotics were
not significantly different within the four collections.
MRSA carriage
The three oxacillin-resistant isolates were confirmed to
carry the mecA gene and to have low-level resistance to
this antibiotic (Table 2). The MRSA isolates were recov-
ered from girls (two aged 3, and one aged 5 years) attend-
ing different DCCs in Oeiras in 2006. One girl had
received three or more courses of antibiotics in the six
months preceding sampling. None had attended a hospi-
tal in the previous six months. Other risk factors associ-
ated with carriage of CA-MRSA were not investigated.
Molecular characterization of MRSA
Molecular characterization was done for the three MRSA
isolates identified in this study as well as for the two ST82
identified in the 1996-1998 study [16]. Two MRSA strains
isolated in 2006 were, by PFGE, related to USA700
(ST72-IV): one strain was of ST939-IVa, spa type t324;
the other was of ST72-IVc, spa type t148 (Figure 1, Table
2). ST939 is a single-locus variant (SLV) of ST72. The spa
types are single repeat variants among each other and
both differ in three repeats from the spa type of USA700
prototype strain (t126).
The third MRSA strain isolated in 2006 was, by PFGE,
related to USA300 (ST8-IV). This isolate was of ST931-
VI, spa type t008. ST931 is a SLV of ST8 and spa type
t008 has been associated with USA300 representatives.
Of notice, this strain had a MIC to oxacillin of 2 mg/L,
below the indicative breakpoint of 4 mg/L.
The three MRSA strains were PVL-negative, but all car-
ried five other virulence genes: lukED, hlg, hlgv, hlb, and
sel (Table 2).
The characterization of the two ST82 isolates described
in the 1996-1998 study confirmed they were related to
each other but not identical: strain DCC1028 was of spa
Table 1: Study collection and distribution of S. aureus isolates
Year Geographic origin Day care centers No. (%)
Nasopharyngeal samples S. aureus MRSA
2006 Oeiras 11 571 92 (16.1) 3 (0.53)
2007 Oeiras 11 538 71 (13.2) 0
2009 Oeiras 9 611 120 (19.6) 0
2009 Montemor-o-Novo 16 380 82 (21.6) 0
Total 2,100 365 (17.4) 3 (0.14)T
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Table 2: Characterization of MRSA strains
Strain ID Isolation year Antibiotypea
(resistant to)
Oxacillin MIC 
(mg/L)
MLST PFGE spa type SCC mec type Virulence factorsb Representative of
RIDOM eGenomics
DCC5292 2006 PEN, OXA 24 939 A1 t324 451
(UJGGMDMGGM)
IVa lukED, hlg, hlgv, hlb, sel USA700
DCC5504 2006 PEN, OXA 2 931 B t008 1049
(YHGFMBOBLO)
VI lukED, hlg, hlgv, hlb, sel USA300
DCC5723 2006 PEN, OXA, ERY, CLI 8 72 A2 t148 193
(UJGFGMDMGGM)
IVc lukED, hlg, hlgv, hlb, sel USA700
DCC1028 1997 PEN, OXA, ERY 12 82 C1 t186 9
(UGFMEEBBPB)
IVa lukED, hlgv, hlb, sel, eta
DCC1076 1997 PEN, OXA, ERY, GEN 24 82 C2 t3221 1190
(UGEBBPB)
IVc lukED, sep, hlg, hlgv, sel
aPEN, penicillin; OXA, oxacillin; ERY, erythromycin; CLI, clindamycin; GEN, gentamicin
bVirulence factors tested: Panton-Valentine leukocidin (pvl), LukE-LukD leukocidin (lukED), class F leukocidin (lukM), staphylococcal enterotoxins (sea-e, seg-j, sel, sep), toxic shock syndrome toxin 
(tsst), exfoliative toxins (eta, etb, etd), and hemolysins (gamma [hlg], gamma variant [hlgv], and beta [hlb])Tavares et al. BMC Infectious Diseases 2010, 10:110
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type t186 and carried SCCmecIVa and the genes lukED,
hlgv, hlb, sel, and eta; strain DCC1076 was of spa type
t3221 and carried SCCmecIVc and the genes lukED, hlg,
hlb, sel, and sep. Both were PVL-negative. The spa types
differed among each other in an insertion/deletion of
three repeats (Table 2).
Discussion
During the last ten years we have been following the
impact of antibiotic use and the introduction of the pneu-
mococcal conjugate vaccine on the bacterial flora colo-
nizing the nasopharynx of preschool children [17,32].
Although the nasopharyngeal sampling in these studies
was designed to recover primarily the major microbial
colonizers of the nasopharyngeal space, such as Strepto-
coccus pneumoniae,  Haemophilus influenzae, and
Moraxella catarrhalis, the method also picks up a sample
of other natural inhabitants of the upper respiratory tract
- such as S. aureus. Thus, nasopharyngeal samples recov-
ered from children in our surveillance program could also
serve as a valuable source of information on possible
changes that may have occurred in the composition of the
natural flora of important human opportunistic patho-
gens, namely S. aureus.
Previous reports of CA-MRSA infections among chil-
dren with no health-care associated risk factors provided
evidence of a hospital-independent community reservoir
[10-12,33]. In addition, other recent studies have identi-
fied risk factors for carriage and transmission of CA-
MRSA, and, consequently, populations at higher risk of
CA-MRSA infections due to their life styles. Due to
crowded conditions, intensive exposure to antimicrobial
agents, and close contact, DCC attendees have also been
considered a high-risk population for carriage of MRSA
[8]. Combined with an increasing incidence of infections
in children with no predisposing risks factors, this popu-
lation has been pointed as a possible community reser-
voir of CA-MRSA. In fact, recent studies from Greece
and Japan reported rates of MRSA nasal carriage of 3.3%
and 3.7%, respectively, corresponding to 5.5% and 9.1% of
MRSA among total S. aureus isolates [13,34]. In Nash-
ville, TN, and Taiwan MRSA nasal carriage rates have
reached 7% to 9% of the sampled population (correspond-
ing to 25-30% of MRSA among all S. aureus isolates)
[29,35]. Finally, studies from Brazil and Illinois, IL,
reported rates of MRSA nasopharyngeal carriage of 1.0%
and 1.7%, respectively, corresponding to 7.5% and 9.3% of
MRSA among total S. aureus isolates [36,37].
In the current study conducted among healthy children
living in the Oeiras and Montemor-o-Novo municipali-
ties of Portugal, we sampled a large group of children
attending DCCs. As in the first study, nasopharyngeal
MRSA colonization was found to be very low (0.24% in
1996-1998 and 0.13% in 2006-2009) [16]. Although we
sampled the nasopharynx, which is not the preferred
niche for S. aureus colonization, the proportion of MRSA
among total S. aureus isolates was still very low: 1.77% in
1996-1998 and 0.82% in 2006-2009. This was a surpris-
ingly low rate, in light of findings from other countries
and knowledge of high prevalence of HA-MRSA in Por-
tugal. However, one of the geographical areas studied is
an urban area densely populated where use of antibiotics
is intense and transmission of potential bacterial patho-
gens among children is known to be high and has been
well documented [17]. In addition, in contrast to other
European countries, in Portugal over 75% of pre-school
children are attending DCCs [17], often since the early
age of 4-5 months, five days a week, eight hours a day.
Figure 1 PFGE pattern of MRSA isolates. Dendrogram resulting from the comparison of PFGE band restriction patterns of the three MRSA strains 
with the band patterns of prototype strains of USA300 and USA700 clones. The dendrogram was generated by the BioNumerics software (version 
5.10, Applied Maths, Gent, Belgium). Patterns were clustered by UPGMA using the Dice similarity coefficient with an optimization of 0.50% and a tol-
erance of 1.3%. PFGE types (clusters) were defined based on a similarity of 80% or higher.Tavares et al. BMC Infectious Diseases 2010, 10:110
http://www.biomedcentral.com/1471-2334/10/110
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Thus, our results may well represent the Portuguese real-
ity.
Another recent study by Lamaro-Cardoso and co-
workers also found a low prevalence (1.2%) of MRSA
among DCC attendees in Brazil. Excluding the fact that
the annual median household income of this population
was below the Brazilian poverty line, only 4 of 14 MRSA
isolates were not associated to health-care settings, and
all had been recovered from children with at least one
risk factor [38].
The three MRSA isolates recovered in the present study
had properties of typical CA-MRSA such as low-level
resistance to oxacillin and limited resistance to non-β-
lactams [9]. Furthermore, by molecular typing they were
identified as related to CA-MRSA clones USA300, a
major epidemic CA-MRSA clone in the USA that is also
spreading in Europe and USA700, a clone that has been
associated to community and health-care settings [39,40].
The MRSA strain related to USA300 carried SCCmec
type VI, which was first described in a nosocomial MRSA
clone identified in Portugal [41]. The two ST82 strains
found a decade ago also showed low-level resistance to
oxacillin and limited resistance to non-β-lactams. In
addition, they carried SCCmec IV, also characteristic of
CA-MRSA. Of interest, the strains isolated in 2006 were
unrelated to these ones. However, MRSA strains of ST88-
IV (ST88 is a SLV of ST82) have been isolated in Portugal
and China in the hospital setting, and in Nigeria and
Switzerland in the community [42-46]. The emergence of
a USA300 related clone among healthy children attending
DCC is worrisome given its acknowledged high capacity
of dissemination that can be rapidly amplified by the high
rates of child-to-child transmission occurring in DCCs.
This study has some limitations. First, we sampled the
nasopharynx, which is not the preferential niche of S.
aureus  and thus we probably underestimated the true
prevalence of MRSA. In particular, we did not sample
other sites of colonization such as anterior nares, throat,
groin, and rectum [47]. Secondly, the study included only
children aged up to six years who are less prone to be col-
onized by S. aureus than older children. Thirdly, we
focused mainly in one urban region, even though a rural
region was also studied in 2009. Although similar results
were found over time and in both geographic locations, it
remains unknown whether the observations made are
representative of Portugal. Regardless of these limita-
tions, we consider that this study contains valuable infor-
mation on the evolution of MRSA carriage in
asymptomatic children.
Conclusions
Our results, based on the analysis of S. aureus isolated
from nasopharyngeal samples, suggest that in Portugal
the prevalence of CA-MRSA carriage in healthy young
children remains extremely low favoring the exclusion of
this group as a reservoir of such isolates. Given the cur-
rent concern about CA-MRSA, the observed emergence
of a USA300 related clone in this study, and the high
prevalence of MRSA causing SSTIs in Portugal [15], an
extension of these studies to other risk groups and con-
tinuous surveillance is mandatory.
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